Why the hospital acquired infection market continues to grow — 5 key points

Here are five things to know:

1. The market focuses on nosocomial infections and infections developed during hospitalization or stays at health facilities. Testing products, device sterilization, specific cleaning products and HAI treatments are included in the market figure.

2. Controlling these infections, as many of the bacteria that cause infection evolve and develop resistance to antimicrobials. New approaches to preventing, diagnosing, and treating such infections will be required for the long-term.

4. HHS strives to combat HAIs by reducing Catheter-Associated Urinary Tract Infection, Central Line-associated Bloodstream Infections, Clostridium difficile, methicillin-resistant Staphylococcus aureus and surgical site infections.

5. Testing for nosocomial infections is a fast-growing market segment thanks to increased awareness of infections.  The treatment segment is the HAI market’s weakest element due to a poor development pipeline. Advanced products capable of treating serious infections offset the challenges, however and may help make it profitable down the road.

More articles on quality & infection control:
OSS Health installs 2 Xenex disinfectant robots — 4 notes

Study shows endometriosis education and awareness is lacking — 4 observationsStudy shows endometriosis education and awareness is lacking — 4 observations

Certified Professional in Patient Safety credential hits 5-year existence — 5 things to knowCertified Professional in Patient Safety credential hits 5-year existence — 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.